J 2023

Short-term risk of periprocedural stroke relative to radial vs. femoral access: systematic review, meta-analysis, study sequential analysis and meta-regression of 2,188,047 real-world cardiac catheterizations

TUZIL, Jan, Jan MATEJKA, Mamas A A MAMAS a Tomáš DOLEŽAL

Základní údaje

Originální název

Short-term risk of periprocedural stroke relative to radial vs. femoral access: systematic review, meta-analysis, study sequential analysis and meta-regression of 2,188,047 real-world cardiac catheterizations

Autoři

TUZIL, Jan (203 Česká republika, garant), Jan MATEJKA (203 Česká republika), Mamas A A MAMAS a Tomáš DOLEŽAL (203 Česká republika, domácí)

Vydání

EXPERT REVIEW OF CARDIOVASCULAR THERAPY, PHILADELPHIA, TAYLOR & FRANCIS INC, 2023, 1477-9072

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30201 Cardiac and Cardiovascular systems

Stát vydavatele

Spojené státy

Utajení

není předmětem státního či obchodního tajemství

Odkazy

Impakt faktor

Impact factor: 2.000 v roce 2022

Kód RIV

RIV/00216224:14110/23:00133372

Organizační jednotka

Lékařská fakulta

UT WoS

000945424600001

Klíčová slova anglicky

Stroke; catheterization; radial; femoral; incidence; observational; cohort; real-world; accession site; meta-analysis; meta-regression; trial sequential analysis

Štítky

Příznaky

Mezinárodní význam, Recenzováno
Změněno: 1. 2. 2024 10:30, Mgr. Tereza Miškechová

Anotace

V originále

ObjectivesTo verify whether transradial (TRA) compared to transfemoral (TFA) cardiac catheterization reduces the risk of periprocedural stroke (PS).MethodsWe reviewed (CRD42021277918) published real-world cohorts reporting the incidence of PS within 3 days following diagnostic or interventional catheterization. Meta-analyses and meta-regressions of odds ratios (OR) performed using the DerSimonian and Laird method were checked for publication bias (Egger test) and adjusted for false-positive results (study sequential analysis SSA).ResultsThe pooled incidence of PS from 2,188,047 catheterizations (14 cohorts), was 193 (105 to 355) per 100,000. Meta-analyses of adjusted estimates (OR = 0.66 (0.49 to 0.89); p = 0.007; I-2 = 90%), unadjusted estimates (OR = 0.63 (0.51 to 0.77; I-2 = 74%; p = 0.000)), and a sub-group of prospective cohorts (OR = 0.67 (0.48 to 0.94; p = 0.022; I-2 = 16%)) had a lower risk of PS in TRA (without indication of publication bias). SSA confirmed the pooled sample size was sufficient to support these conclusions. Meta-regression decreased the unexplained heterogeneity but did not identify any independent predictor of PS nor any effect modifier.ConclusionPeriprocedural stroke remains a rare and hard-to-predict adverse event associated with cardiac catheterization. TRA is associated with a 20% to 30% lower risk of PS in real-world/common practice settings. Future studies are unlikely to change our conclusion.